MarketInOut Stock Screener Log In | Sign Up

Provexis Plc

LSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 15:49
Provexis Plc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeLSE
Market Capitalization19.94 mln
Float2,102 mln
Earnings Date12/18/2026

Piotroski F-Score

4 / 9
Borderline

Relative Strength

1 / 100
Severely lagging

Pre-Tax Margin

-40%
Deeply loss-making

ROE

-42.51
Deeply negative

Altman Z-Score

-4.12
Deeply distressed

ROA

-47.90
Deeply negative

Business Description

Provexis plc is a UK-based company that develops and sells health-focused food products and dietary supplements around the world. Its main offering is Fruitflow, a tomato-based ingredient available in syrup and powder form that helps support healthy blood flow and reduces the risk of clotting linked to heart attacks and strokes. The company also sells Fruitflow+ Omega-3 as a standalone supplement. Products are available online and through a network of distributors.

Key Fundamentals

EPS-0.01
ROE-42.51
RPS0.00
ROIC-1,023
ROA-47.90
EBITDA, mln-0.51
EV / EBITDA-39.99
EV / EBIT-39.99
Revenue, mln1.26
EV / Revenue16.03

Quote Details

Last 0.85
Change -0.25 (-22.73%)
Open 1.04
Volume 238,260
Turnover 202,521
Average Volume 407,834

Financial Ratios

Pre-Tax Profit Margin-40
Leverage Ratio1.17
Current Ratio1.79
Price / Book18.03
Price / Cash Flow111
Price / Free Cash Flow111
Price / Sales9.40

Financial Strength

Altman Z-Score-4.12
Piotroski F-Score 4 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 6.25% 96 / 100   
1 Month -10.53% 10 / 100   
2 Months -19.81% 7 / 100   
6 Months -16.67% 12 / 100   
1 Year 21.43% 78 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog